Approach to Classifying “Design” Drugs and New Potentially Dangerous Chemical Substances, With a Brief Review of the Problem

APA 6th edition
In-text: (Asadullin, Galeeva, Achmetova & Nikolaev, 2016)
Your Bibliography: Asadullin, A.R., Galeeva, E.K., Achmetova, E.A. & Nikolaev, I.V. (2016). Approach to Classifying “Design” Drugs and New Potentially Dangerous Chemical Substances, With a Brief Review of the Problem. International Journal of Environmental and Science Education, 11(14), 6697-6703.

Harvard
In-text: (Asadullin, Galeeva, Achmetova and Nikolaev, 2016)
Your Bibliography: Asadullin, A., Galeeva, E., Achmetova, E. and Nikolaev, I. (2016). Approach to Classifying “Design” Drugs and New Potentially Dangerous Chemical Substances, With a Brief Review of the Problem. International Journal of Environmental and Science Education, 11(14), pp. 6697-6703.

Chicago 16th edition
In-text: (Asadullin, Galeeva, Achmetova and Nikolaev 2016)
Your Bibliography: Asadullin, Azat R., Elena Kh. Galeeva, Elvina A. Achmetova and Ivan V. Nikolaev (2016). "Approach to Classifying “Design” Drugs and New Potentially Dangerous Chemical Substances, With a Brief Review of the Problem". International Journal of Environmental and Science Education 11 (14):6697-6703.

Abstract

The urgency of this study has become vivid in the light of the growing problem of prevalence and use of new synthetic drug types. Lately there has been a tendency of expanding the range of psychologically active substances (PAS) used by addicts with the purpose of their illegal taking. The aim of this research is an attempt of systematizing and classifying “design” drugs according to their chemical structure, neurochemical mechanisms of action and clinical manifestations. As a result, we have found that they can be divided into ten big groups. This classification will allow to better arrange new clinical phenomenology in modern addictology. This paper would be useful for psychiatrists, experts in narcology, as well as for personnel of institutions and agencies engaged in anti-drug activity.

Keywords: Opiates, cannabinoids, cathinones, tryptamine, cocaine, pregabalin, new “design” drugs, classification

References

Abbott, R. & Smith, D. E. (2015). The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis, Journal of Psychoactive Drugs, 5, 368-371.

Akhmetova, E. А., Galeeva, Е. H., Asadullin, А. R., Nikolaev, I. V. & Illarionov, М. V. (2016). Peculiarities of prevalence and consumption of the latest synthetic "designer" drugs on the territory of the Republic of Bashkortostan. Тоmsk: Publishing house “Ivan Fedorov”, 300 p.

Arunotayanun, W., Dalley, J. W. & Huang, X. P. (2013). An analysis of the synthetic tryptamines AMT and 5-MeO-DALT. Bioorganic & medicinal chemistry letters, 11, 3411 - 3415.

Asadullin, А. R., Akhmetova, E. А. & Uritsky, B. L. (2015). The pathomorphism of clinical forms of drug addiction. New synthetic drugs. Materials of all-Russian conference on "Current issues of addictology - new opportunities of pharmacological psychotherapy and rehabilitation", 20-25.

Bokhan, N. А. & Selivanov, G. Y. (2015). Clinical typology of psychopathological disorders in users of synthetic cannabinoids (spice), Siberian Gerald of Psychiatry and Addiction Psychiatry, 4, 18-23.

Chavant, F. (2015). New synthetic drugs in addictovigilance, Thérapie, 2, 179-189.

Golovko, А. I. & Bonitenko, Е. Y., (2015). Terminological and biological paradoxes of the phenomenon of "design narcotics". Narcology, 8, 69-83.

Helander, A., Beackberg, M. & Beck, O. (2014). MT-45, a new psychoactive substance associated with hearing loss and unconsciousness, Clinical Toxicology, 4, 176-185.

Ismailova, Y. S. (2013). Addiction, morphine and morphinism, Scientific-Practical Journal of Medicine, 4, 55-67.

Krupitsky, E. M. (2016). Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial, Journal of Neurology and Psychiatry, 7, 29 – 36.

Lowe, L. M. (2015). A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State Journal of analytical toxicology, 8, 668-671.

Mendelevich, V. D. (2014). Psychotic disorder as the result of drug abuse: current state of the problem. Narcology, 7, 93—100.

Nenastieva, A. U., Rokhlina, M. L., Usmanova, N. N. & Zakharov, E. D. (2015). Abuse of pregabalin, Materials of all-Russian scientific-practical conference with international participation "Psychiatry is at the stage of reforms: problems and prospects", 5, 119-126.

Poklis, J. L. (2015). Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper, Journal of analytical toxicology, 8, 617-623.

Shevyrin, V. A. & Morzherin, Yu. Yu. (2015). The structure, operation and classification of cannabis, Izvestiya akademii nauk. Proceedings of the Academy of Sciences, 11, 1249-1266.

Vorce, S. P. (2014). A fatality involving AH-7921, Journal of analytical toxicology, 4, 226-230.